17 results
10-K
2023 FY
EX-10.8
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
10-K
2023 FY
EX-10.7
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
10-K
2023 FY
EX-10.9
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
10-K
2023 FY
EX-10.10
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
10-K
2023 FY
EX-10.4
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
F-1
EX-10.15
4wahlvhgs jn
19 Dec 22
Registration statement (foreign)
6:22pm
F-1
EX-10.5
w6q0v3
19 Dec 22
Registration statement (foreign)
6:22pm
F-1
EX-10.13
5e1kvlpz8qgg
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
EX-10.1
zh80uy7
19 Dec 22
NewAmsterdam Announces Appointment of David Topper as Chief Financial Officer
4:23pm
F-4/A
EX-10.13
x3iqgz qw1i
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
EX-10.7
y83945stkr1g 1aev
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
EX-10.14
nly2mo
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
EX-10.11
t0rd370
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4/A
EX-10.9
3lpm 4kj4ugbkg984
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4/A
EX-10.10
tvq sy7n6
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4/A
EX-10.12
06a hnonwbe
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4
EX-10.8
tthctge
4 Aug 22
Registration of securities (foreign)
8:02am
- Prev
- 1
- Next